Navigation Links
Gel / Mount mounting medium - fluorescence from GeneTex

ProductsGel / Mount mounting medium - fluorescence from GeneTex
Company GeneTex
Item Gel / Mount mounting medium - fluorescence
Price $140.00
Description Gel/Mount is an aqueous-based mounting medium designed for the preservation of fluorescence-stained tissue sections. Gel/Mount is especially recommended when using tracers containing phycoerythrin, phycocyanin, allophycocyanin or FluoroBlue. It can also be used with conventional fluorescent tracers such as fluorescein (FITC), Rhodamine (TMRITC) and Texas Red. Gel/Mount is a non-glycerol based mounting medium. It is specially formulated without glycerol to avoid the deleterious effects of this compound in some of the phycobili-protein based detection systems. This makes Gel/Mount the mounting medium of choice when phycobili proteins are used as tracers. This product is not suitable for binary substrates generally used for immunohistochemistry. A product like Crystal/Mount (aqueous mounting media) or Clarin (organic mounting media) should be used.
Info GeneTexGeneTex
14785 Omicron Dr. Suite101
San Antonio, TX 78245
Customer Service: (877) 436-3839
Fax Number: (210) 677-8843
Web Site: http://www.genetex.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Vision Mount from Lab Vision
2. Faramount, Aqueous Mounting Medium, Ready-to-Use from Dako
3. Fluorescent Mounting Media from KPL
4. Mechanical Cell Strain Instrument ST-160 Microscope Mountable from B-Bridge International
5. Mechanical Cell Strain Instrument STREX ST-195 Microscope Mountable from B-Bridge International
6. Mechanical Cell Strain Instrument STREX ST-190-XY Microscope Mountable from B-Bridge International
7. Mounting Medium from BioVision
8. Crystal / Mount mounting medium - general purpose from GeneTex
9. Mounting Medium from R&D Systems
10. Clarion Mounting Medium - 6X100 ml from Biomeda Corporation
11. Mounting Medium for Histochemistry from CHEMICON
...
Jak3 Antibody Ship: Hot Store: -20 C...
WASF2 Immunogen: WASF2 (NP_008921, 73 a.a. ~ 173 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Applications: Western blotting Stability: Room temperature, indefinitely ...
Biology Products:
(Date:3/31/2015)... 31, 2015   Guidepoint , a leading global ... Post-Surgical Pain Management TRACKER, part of the Guidepoint ... in the medical device and therapeutics markets. The Post-Surgical ... treatment volumes, market share, and adoption rates across three ... joint surgery. The Post-Surgical Pain Management TRACKER ...
(Date:3/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) ... Recognition Market 2015-2019" report to their offering. ... to grow at a CAGR of 23.5 percent over ... present scenario and the growth prospects of the Global ... the market size, the report considers the revenue generated ...
(Date:3/24/2015)... Fla. , March 24, 2015   ... management solutions, today announced that its U.are.U ® ... accessory retailer Goorin Bros . to achieve ... biometrics-based solution secures access to the POS terminal, ... increased risk of data breaches. ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2
... Duke University-led study has documented dramatic, natural short-term increases in ... "The natural short-term variability in acidity we observed over the ... ocean as a whole and may already be exerting added ... that are especially susceptible to changes in pH," said Zackary ...
... the Florida campus of The Scripps Research Institute have revealed ... form of muscular dystrophy, myotonic dystrophy type 2, and have ... counter those defectsand reverse the disease. "This the first ... disease has been determined," said TSRI Associate Professor Matthew Disney, ...
... bulging or protruding intervertebral discs occupies the intervertebral foramen, ... nerve root fibers is reduced, fiber bundles gathered together ... Dr. Xin Tian and colleagues from the Second Hospital ... to use diffusion tensor tractography to reveal spinal nerve ...
Cached Biology News:Local factors cause dramatic spikes in coastal ocean acidity 2Scientists uncover image of muscular dystrophy defect & design targeted drug candidates 2
(Date:4/16/2015)...  Schulman Associates IRB, Inc., the industry-leading central IRB ... lease on Laboratory Drive in the heart of ... location will house review board and service staff, which ... and customer service to clients. CBRE ... the deal, while Capital Associates Management, LLC represented the ...
(Date:4/16/2015)... 16, 2015 OncoTAb, Inc., ... (UNC Charlotte) spin-out company, announced today the appointment ... M.D., as Chief Operating Officer (COO). Cooper brings ... in developing clinical diagnostic and biotechnology platforms in ... , Cooper’s extensive career transcends the field of ...
(Date:4/16/2015)... - Portage Biotech Inc. ("Portage" or "the Company" )) ... to announce that the Company will be presenting  at ... be held in London, UK . ... James Mellon , a director of Portage, will ... programs at its subsidiaries, Portage Pharmaceuticals Ltd. ("PPL"), and ...
(Date:4/16/2015)... , April 16, 2015 ... the Russian pharmaceutical investment and R&D group, ... collaboration for research, development and commercialization of ... with the intention to stimulate the ...      (Logo: http://photos.prnewswire.com/prnh/20150416/739742-a) ,     (Logo: ...
Breaking Biology Technology:Schulman IRB to Open Office in Research Triangle Park, N.C. 2OncoTAb Names Dr. David L. Cooper as COO 2Portage to Present at Master Investor 2015 in London, UK 2Portage to Present at Master Investor 2015 in London, UK 3Portage to Present at Master Investor 2015 in London, UK 4Lancet and ChemRar High Tech Center Have Announced a Partnership in the Development and Production of Novel Drugs in Russia 2